Evaluation of intra-tympanic dexamethasone in meniere disease
Not Applicable
- Conditions
- Meniere disease.Ménière disease
- Registration Number
- IRCT2014050112691N2
- Lead Sponsor
- Tehran University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 23
Inclusion Criteria
Definite meniere ; Age beyond 18 years; NOresponse to medical mangment
Exclusion criteria:
Musculoskeletal disease ; Spinal cord disease; Middle ear disease ; Addiction ;Usage of ototoxic drugs
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Vertigo. Timepoint: 1 ; 3 and 6 months. Method of measurement: In respect to standardized questionarie.
- Secondary Outcome Measures
Name Time Method Tinitus ;hearing level. Timepoint: 1 ; 3 and 6 months. Method of measurement: Audiometry / respect to questionarie.